Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7721245

Concept As at
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2018-03-31
As at
2018-03-31
As at
2017-06-30
2017-04-01 to
2017-06-30
Key financial data of group
Business results of group
Net sales
24,135,000,000 JPY
98,430,000,000 JPY
24,967,000,000 JPY
Ordinary profit (loss)
5,817,000,000 JPY
27,854,000,000 JPY
7,813,000,000 JPY
Profit (loss) attributable to owners of parent
4,035,000,000 JPY
19,043,000,000 JPY
5,463,000,000 JPY
Comprehensive income
4,232,000,000 JPY
20,753,000,000 JPY
6,300,000,000 JPY
Net assets
112,514,000,000 JPY
113,874,000,000 JPY
104,101,000,000 JPY
Total assets
148,763,000,000 JPY
152,417,000,000 JPY
138,909,000,000 JPY
Basic earnings (loss) per share
100.16
470.54
133.81
Diluted earnings per share
Equity-to-asset ratio
0.756 xbrli:pure
0.747 xbrli:pure
0.749 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.